Basic research for regulation and disorder of cardiac Ca signal
心脏Ca信号调控与紊乱的基础研究
基本信息
- 批准号:14370778
- 负责人:
- 金额:$ 9.09万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In cardiovascular disorders, including myocardial infarction and heart failure, various endogenous regulators are released from divergent types of cell, such as endothelial cells, and play crucial role in progress and recovery of diseases. In chronic congestive heart failure, it has been considered that the myocardial contractile dysfunction is the key process of the disorder and the cardiotonic agents that reverse the dysfunction may be the primary target of drug therapy of the disease. The current therapeutic target has been recognized to be addressed to the suppression of modulatory mechanisms, such as adrenergic regulation, rennin-angiotensin and aldosterone system, in addition to cardiac unloading by reduction of pre-load and after-load. In heart failure it has been elucidated that the plasma levels of norepinephrine (NE) and endothelin-1 (ET-1) are elevated in the course of progress of severity of the disease. It is highly likely that NE and ET-1 regulate the myocardial contracti … More lity in patients with heart failure. We investigated, therefore, the regulation of myocardial contractility and Ca^<2+> by crosstalk of NE with ET-1 in canine ventricular myocardium and single myocytes. ET-1 alone did not cause any inotropic effect on canine ventricular myocardium, but induced complex regulation depending on the co-existing concentrations of NE. In the presence of NE around threshold concentrations (10^<-10>〜10^<-9>mol/L) ET-1 elicited a concentration-dependent positive inotropic effect (PIE) in association with an increase in myofilament Ca^<2+> sensitivity. The PIE of ET-1 is unique in that it requires simultaneous activation of both PKA and PKC. It is of interest that the activation of PKA has been established to shift the relationship of contractile force and [Ca^<2+>]_i to the right to direction implying a decrease in myofilament Ca^<2+> sensitivity due to phosphorylation of troponin I and phosphlamban (leading to SERCA2a activation). In contrast, it became evident that the activation of PKA by crosstalk with PKC activation elicits a PIE in association with an increase in myofilament Ca^<2+> sensitivity. The PIE of ET-1 was abolished by the PKA inhibitor, PKC inhibitor, PLC inhibitor or β-blocker. The present results imply that the crosstalk of NE and ET-1 plays a crucial role in contractile regulation in patients with heart failure. Less
在包括心肌梗塞和心力衰竭在内的心血管疾病中,各种内源性调节剂从不同类型的细胞(例如内皮细胞)中释放出来,并在疾病的进展和恢复中起着至关重要的作用。在慢性充血性心力衰竭中,人们认为心肌收缩功能障碍是该疾病的关键过程,而逆转功能障碍的心差可能是该疾病药物治疗的主要靶点。当前的治疗靶标已被认为是针对调节机制的抑制,例如肾上腺素调节,肾上腺素 - 血管紧张素和醛固酮系统,除了通过减少预载和后负载和后负载和卸载。在心力衰竭中,已经阐明了在疾病严重程度进展的过程中,去甲肾上腺素(NE)和内皮素-1(ET-1)的血浆水平升高。 NE和ET-1很有可能调节心肌肌的心肌……对心力衰竭患者更有责任。因此,我们研究了心肌收缩性的调节,并通过NE与犬室心肌和单个心肌细胞中的ET-1串扰对CA^<2+>调节。仅ET-1就不会对犬心室心肌产生任何肌力作用,而是根据NE的共存浓度诱导复杂调节。在存在周围阈值浓度(10^<-10> 10^<-9> mol/l)的情况下,ET-1与肌丝Ca^<2+敏感性的增加相关的浓度依赖性阳性肌效应(PIE)。 ET-1的馅饼是独一无二的,因为它需要简单地激活PKA和PKC。人们很感兴趣的是,已经建立了PKA的激活,以将收缩力的关系和[Ca^<2+>] _ I转移到方向的权利,这意味着肌丝Ca^<2+>>敏感性降低,肌肉I和phosponin I和phosphlamban(导致Serca2A激活)。相比之下,证据表明,通过与PKC激活串扰PKA的激活引起了一种与肌丝Ca^<2+>敏感性增加相关的PIE。 PKA抑制剂,PKC抑制剂,PLC抑制剂或β受体阻滞剂消除了ET-1的馅饼。目前的结果表明,NE和ET-1的串扰在心力衰竭患者的收缩调节中起着至关重要的作用。较少的
项目成果
期刊论文数量(28)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sakurai, K.: "Negative inotropic effects of angiotensin II, endothelin-1 and phenylephrine in indo-1 loaded adult mouse ventricular myocytes"Life Sci.. 70. 1173-1184 (2002)
Sakurai, K.:“血管紧张素 II、内皮素-1 和去氧肾上腺素对装载 indo-1 的成年小鼠心室肌细胞的负性肌力作用”生命科学 70. 1173-1184 (2002)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Endoh, M.: "Mechanism of action of sensitizers-Update 2001"Cardiovasc.Drugs and Therapy. 15. 397-403 (2001)
Endoh, M.:“敏化剂的作用机制 - 2001 年更新”Cardiovasc.Drugs and Therapy。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ichiyanagi, O.: "Angiotensin II increase L-type Ca^<2+> current ingramicidin D-perforated adult rabbit ventricular myocytes : comparison with conventional patch-clamp method"Pflugers Arch-Eur J. Physiol. 444. 107-116 (2002)
Ichiyanagi, O.:“血管紧张素II增加L-型Ca^2>电流ingramicidin D-穿孔成年兔心室肌细胞:与传统膜片钳方法的比较”Pflugers Arch-Eur J. Physiol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ichiyanagi, O.: "Angiotensin II increase L-type Ca^<2+> ingramicidin D-perforated adult rabbit ventricular myocytes : comparison with conventional patch-clamp method"Pflugers Arch-Eur J.Physiol. 444. 107-116 (2002)
Ichiyanagi,O.:“血管紧张素II增加L-型Ca ^ 2 > ingramicidin D-穿孔成年兔心室肌细胞:与传统膜片钳方法的比较”Pflugers Arch-Eur J.Physiol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Endoh, M.: "Mechanisms of action of novel cardiotonic agents."J.Cardiovasc.Pharmacol. 40. 323-338 (2002)
Endoh, M.:“新型强心剂的作用机制。”J.Cardiovasc.Pharmacol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ENDOH Masao其他文献
ENDOH Masao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ENDOH Masao', 18)}}的其他基金
Molecular pharmacological research for regulation and disorder of cardiac myocytes
心肌细胞调控与紊乱的分子药理学研究
- 批准号:
16390064 - 财政年份:2004
- 资助金额:
$ 9.09万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
MORECULAR PHARMACOLOGICAL STUDY OF SIGNAL TRANSDUCTION
信号转导的更常规药理学研究
- 批准号:
11470021 - 财政年份:1999
- 资助金额:
$ 9.09万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of Novel Therapeutic Agents for Treatment of Congestive Heart Failure by Means of Model Animals
通过模型动物开发治疗充血性心力衰竭的新型治疗剂
- 批准号:
11557203 - 财政年份:1999
- 资助金额:
$ 9.09万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of new drugs for the treatment of congestive heart failure
治疗充血性心力衰竭新药的开发
- 批准号:
07557193 - 财政年份:1995
- 资助金额:
$ 9.09万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Development of novel cardiotonic agents
新型强心剂的开发
- 批准号:
04557009 - 财政年份:1992
- 资助金额:
$ 9.09万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
A Molecular Mechanism, of Myocardial alpha-Adrenoceptor-mediated Signaltransductio
心肌α-肾上腺素受体介导的信号转导的分子机制
- 批准号:
03454142 - 财政年份:1991
- 资助金额:
$ 9.09万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似国自然基金
蓝斑去甲肾上腺素能神经元调控小胶质细胞活化在右美托咪定脑保护中的作用及机制研究
- 批准号:82371285
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于APOE介导蓝斑去甲肾上腺素神经元损伤与Aβ-Tau蛋白交互协同作用诱导阿尔茨海默病神经退变机制的研究
- 批准号:82371999
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于多模态PET/MR代谢脑网络探讨蓝斑-去甲肾上腺素系统参与认知老化的机制
- 批准号:82301789
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
去甲肾上腺素调控肺泡上皮细胞焦亡在ARDS中的作用及机制研究
- 批准号:82301442
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
蓝斑-中央杏仁核去甲肾上腺素能通路介导的脑-脾轴在脓毒症相关性谵妄与神经-免疫调控中的作用及其机制研究
- 批准号:82372199
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
In Vivo Mechanisms of Integrated G protein Signaling Regulation by RGS Proteins
RGS 蛋白整合 G 蛋白信号传导调节的体内机制
- 批准号:
10077581 - 财政年份:2018
- 资助金额:
$ 9.09万 - 项目类别:
Circadian mechanisms of cardiovascular risk in obesity
肥胖者心血管风险的昼夜机制
- 批准号:
9973192 - 财政年份:2017
- 资助金额:
$ 9.09万 - 项目类别:
Vasoactive Agents and Cerebral Outcomes in Brain Injury
血管活性药物和脑损伤中的脑结果
- 批准号:
9148197 - 财政年份:2015
- 资助金额:
$ 9.09万 - 项目类别:
Pressor Choice Influences Protection Of Autoregulation in Brain Injury
加压剂选择影响脑损伤中自动调节的保护
- 批准号:
9331755 - 财政年份:2015
- 资助金额:
$ 9.09万 - 项目类别:
Vasoactive Agents and Cerebral Outcomes in Brain Injury
血管活性药物和脑损伤中的脑结果
- 批准号:
9029235 - 财政年份:2015
- 资助金额:
$ 9.09万 - 项目类别: